about
Treatment of recurrent depressionResidual symptoms in depression an emerging therapeutic concept.Erratum to "CNS drugs in Cushing's disease: pathophysiological and therapeutic implications for mood disorders" [Prog. Neuro-Psycol. Biol. Psychiatry, 26, 763 (2002)].Residual symptoms in depression: an emerging therapeutic target.Self image and quality of life in acromegaly.Prevalence and natural history of adrenal incidentalomas.Treatment of recurrent depression: a sequential psychotherapeutic and psychopharmacological approach.The clinical domains of psychosomatic medicine.Psychosocial approach to endocrine disease.Rehabilitation in endocrine patients: a novel psychosomatic approach.New strategies in the assessment of psychological factors affecting medical conditions.Psychosomatic aspects of Cushing's syndrome.Psychosomatic medicine is a comprehensive field, not a synonym for consultation liaison psychiatry.The spectrum of adjustment disorders: too broad to be clinically helpful.Principles of psychosomatic assessment.The unifying concept of illness behavior.Mood and anxiety disorders as early manifestations of medical illness: a systematic review.The Psychosomatic Practice.Use of the Psychosocial Index: A Sensitive Tool in Research and Practice.Current Psychosomatic Practice.Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism.Psychosomatic characterization of adjustment disorders in the medical setting: some suggestions for DSM-V.Irritable mood in Italian patients with medical disease.Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome.Management of recurrent depression in primary care.Adiponectin and insulin sensitivity in primary aldosteronism.Psychological aspects of primary aldosteronism.Tolerance to antidepressant treatment may be overcome by ketoconazole. Report of two cases.Coronary microvascular function in patients with Cushing's syndrome.Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome.Iatrogenic comorbidity in childhood and adolescence: new insights from the use of antidepressant drugs.Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients.Alexithymia in the medically ill. Analysis of 1190 patients in gastroenterology, cardiology, oncology and dermatology.Should we evaluate for cardiovascular disease in patients with Cushing's syndrome?Galactorrhea with aripiprazole.Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.Personality characteristics and quality of life in patients treated for Cushing's syndrome.Left ventricular structural and functional characteristics in Cushing's syndrome.The biopsychosocial model thirty years later.Circadian blood pressure patterns and life stress.
P50
Q22305946-4959F111-3315-46F3-A488-C335219CBB5EQ34790197-503806BB-5F1F-4B71-B33F-97C9E54D1AE3Q34945094-50F33420-42E2-414C-A457-16A13FFDD649Q35009395-5B28DCB8-3AB6-4376-AF22-2756CF4B73B1Q35085826-2207E5AA-EFD8-4D78-BDDC-8D158390C3E5Q35545628-6A9E7B47-0D82-48E9-9276-7D4ED8B7B8FBQ35602618-B1F16441-465A-4604-ADBA-2B6B5553EB7FQ36192632-D3D551BC-75C1-45C1-8395-6647B0745FEDQ36904174-33AF9787-722D-481A-BB4F-3FDB962986B8Q36961365-543A0C4D-2F03-4C4A-A396-CE7317DAD21BQ37000709-7CB78980-E945-4D94-BEE4-57C3E8EDD2B5Q37644244-79563B1C-53D3-4AFE-A456-C53850A7C5BBQ37738375-589561B0-674A-4581-A24C-86A2AF6D3670Q37772074-9003D8B4-69B8-4F20-B408-DB4DE34EC4F1Q37953164-AB47E3C1-266C-4B04-820F-96F6CE99718EQ38072202-218EDD62-8B33-4D00-B152-7A7456E97551Q38303153-1E14DCC6-C028-4E5C-BE84-B842437EF4AAQ38860364-752CF09A-6675-4B45-A809-4F1D7E0F10C6Q38981698-9ADCD969-C909-4A3B-81FB-C305EB5762F2Q39018849-B9ECB298-9485-4DBC-8985-EAF5491A743DQ42471716-0D061B71-DD1A-44EC-885B-335AE5211E84Q43649060-5CCE839D-A0D2-4E19-86AC-51FD587D9502Q44033312-4D027534-C5EB-4992-886F-6E535B9AF5C8Q44089038-9ED6520C-8F4D-4CAA-835C-09CD1B3C2D89Q44238881-1E2606CA-1B0D-4B4C-89F5-B644DE4BB3AFQ44243946-FE0F38EE-B801-40F3-B7CD-A56682EA4A1DQ44278811-0E620843-CE25-4DDC-8EA5-6575214BE346Q44501304-F42BE965-DC51-4D31-9128-22BA9E8801E8Q44517743-B21B4178-78E5-4B41-9264-82E2CD489B60Q44794003-80B2B58B-A9AD-464D-B758-EDA7885E966BQ44798643-E83DAB06-24C3-404A-9727-02714546BF31Q45251116-3F0F15BE-7012-4A3E-A88B-30DEC37F1C66Q45810575-30732D49-ED02-4093-B6FA-8D6EF2DCBB63Q45976549-68E0E7D4-D0AA-4FA2-9DA5-8B84C1E16451Q46770157-EB1262A1-E97C-4BE4-AC1E-E5F1D02CC489Q46807615-3BE044A3-745C-4BC3-99B8-8E54D56A42F4Q46951305-4BC2118F-1D8D-4848-937B-6FAB43E3282DQ47811261-D4B6323F-BCA5-4D38-8802-C806F16AFFE2Q48538751-7B7BC365-5AC1-4950-ADEC-3ADD59055D8AQ48646601-991322E0-44AE-4CE1-8AB5-6437D566CB09
P50
name
Nicoletta Sonino
@ast
Nicoletta Sonino
@en
Nicoletta Sonino
@nl
type
label
Nicoletta Sonino
@ast
Nicoletta Sonino
@en
Nicoletta Sonino
@nl
prefLabel
Nicoletta Sonino
@ast
Nicoletta Sonino
@en
Nicoletta Sonino
@nl
P214
P214
P31
P7859
lccn-n2007182824